PROCTER & GAMBLE HEALTH | S.S.ORGANICS | PROCTER & GAMBLE HEALTH/ S.S.ORGANICS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | -8.4 | - | View Chart |
P/BV | x | 10.6 | - | - | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH S.S.ORGANICS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
S.S.ORGANICS Mar-23 |
PROCTER & GAMBLE HEALTH/ S.S.ORGANICS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 41 | 13,235.3% | |
Low | Rs | 3,883 | 21 | 18,490.5% | |
Sales per share (Unadj.) | Rs | 740.7 | 21.8 | 3,394.5% | |
Earnings per share (Unadj.) | Rs | 138.2 | -8.1 | -1,696.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -6.7 | -2,314.6% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | -32.5 | -1,375.8% | |
Shares outstanding (eoy) | m | 16.60 | 14.20 | 116.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.4 | 442.7% | |
Avg P/E ratio | x | 33.5 | -3.8 | -885.8% | |
P/CF ratio (eoy) | x | 29.8 | -4.6 | -649.2% | |
Price / Book Value ratio | x | 10.3 | -0.9 | -1,092.2% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 437 | 17,566.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 11 | 18,116.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 310 | 3,968.2% | |
Other income | Rs m | 184 | 0 | 102,166.7% | |
Total revenues | Rs m | 12,480 | 310 | 4,025.2% | |
Gross profit | Rs m | 3,247 | -79 | -4,135.5% | |
Depreciation | Rs m | 281 | 21 | 1,369.4% | |
Interest | Rs m | 8 | 15 | 51.7% | |
Profit before tax | Rs m | 3,142 | -114 | -2,762.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 2 | 42,792.9% | |
Profit after tax | Rs m | 2,295 | -116 | -1,983.1% | |
Gross profit margin | % | 26.4 | -25.3 | -104.2% | |
Effective tax rate | % | 27.0 | -1.7 | -1,546.6% | |
Net profit margin | % | 18.7 | -37.3 | -50.0% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 250 | 4,684.0% | |
Current liabilities | Rs m | 6,791 | 298 | 2,277.5% | |
Net working cap to sales | % | 40.0 | -15.5 | -257.8% | |
Current ratio | x | 1.7 | 0.8 | 205.7% | |
Inventory Days | Days | 263 | 16 | 1,658.5% | |
Debtors Days | Days | 343 | 119,672,906 | 0.0% | |
Net fixed assets | Rs m | 10,617 | 293 | 3,628.7% | |
Share capital | Rs m | 166 | 142 | 116.9% | |
"Free" reserves | Rs m | 7,265 | -604 | -1,202.7% | |
Net worth | Rs m | 7,431 | -462 | -1,608.3% | |
Long term debt | Rs m | 0 | 630 | 0.0% | |
Total assets | Rs m | 22,330 | 543 | 4,114.9% | |
Interest coverage | x | 409.1 | -6.6 | -6,157.5% | |
Debt to equity ratio | x | 0 | -1.4 | -0.0% | |
Sales to assets ratio | x | 0.6 | 0.6 | 96.4% | |
Return on assets | % | 10.3 | -18.6 | -55.5% | |
Return on equity | % | 30.9 | 25.0 | 123.3% | |
Return on capital | % | 42.4 | -58.8 | -72.1% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 0 | - | |
Fx outflow | Rs m | 1,605 | 0 | - | |
Net fx | Rs m | -140 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | -16 | -14,443.1% | |
From Investments | Rs m | -215 | -96 | 223.0% | |
From Financial Activity | Rs m | -985 | 112 | -877.3% | |
Net Cashflow | Rs m | 1,160 | 0 | -236,795.9% |
Indian Promoters | % | 0.0 | 29.7 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 66,566.7% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 70.3 | 68.6% | |
Shareholders | 56,778 | 10,102 | 562.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | S.S.ORGANICS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 4.76% | 0.45% |
1-Month | -1.15% | 36.91% | 2.55% |
1-Year | 0.73% | 33.01% | 56.14% |
3-Year CAGR | -8.76% | 60.61% | 15.22% |
5-Year CAGR | 4.97% | 34.73% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the S.S.ORGANICS share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of S.S.ORGANICS the stake stands at 29.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of S.S.ORGANICS.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
S.S.ORGANICS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of S.S.ORGANICS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.